 BioMarin CEO JJ Bienaimé joins Yahoo Finance Lives Julie Hyman and Anjalee Khemlani to discuss the companys first gene therapy product targeted to patients dealing with hemophilia, the future of biotechnology, biotech stocks, and key takeaways from JPMorgans annual health care conference. 